NewGen BioPharma Corp. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/249858f5-0972-4852-8216-eaff8709bd04/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-41.9k | 2015-11-01 – 2016-10-31 | evidence 0001640334-17-000168 |
| FY 2015 | $-33.4k | 2014-11-01 – 2015-10-31 | evidence 0001640334-16-000631 |
| FY 2014 | $-43.0k | 2013-11-01 – 2014-10-31 | evidence 0001557240-15-000057 |
| FY 2013 | $-98.6k | 2010-02-25 – 2014-04-30 | evidence 0001557240-14-000330 |
| FY 2012 | $-42.9k | 2010-02-25 – 2013-04-30 | evidence 0001165527-13-000591 |
| FY 2011 | $-7.3k | 2010-11-01 – 2011-10-31 | evidence 0001557240-14-000067 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NewGen BioPharma Corp. — all facts · Revenue · Operating Income